Citadel Advisors’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Citadel Advisors’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,200	Closed	-$143K	–	15606
2024 Q2	$143K	Sell	4,200 -500	-11%	-$14.8K	﹤0.01%	10409
2024 Q1	$165K	Sell	4,700 -7,900	-63%	-$265K	﹤0.01%	10617
2023 Q4	$364K	Sell	12,600 -37,900	-75%	-$903K	﹤0.01%	8756
2023 Q3	$1.16M	Buy	50,500 +42,600	+539%	+$2.24M	﹤0.01%	6273
2023 Q2	$453K	Sell	7,900 -9,000	-53%	-$470K	﹤0.01%	8162
2023 Q1	$636K	Buy	16,900 +15,800	+1,436%	+$582K	﹤0.01%	7807
2022 Q4	$29.4K	Buy	+1,100	New	+$30.1K	﹤0.01%	12773

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Citadel Advisors's MORF Position: Q3 2024 in Review

Citadel Advisors sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 161,988 shares — an estimated $5.52M sold.

Citadel Advisors first reported a position in MORF in Q2 2019 and held it in 16 quarters. The position peaked at $30.5M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Citadel Advisors reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Citadel Advisors sold 161,988 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $5.52M.
Citadel Advisors first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
Citadel Advisors's Morphic Holding, Inc. Common Stock position peaked at $30.5M in Q1 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.